In vitro studies suggested a tumor-suppressive role for both YY1 and the hereby identified pro-apoptotic factor BCL2L15/Bfk, in two out of four CRC cell lines with different mutational genotypes. This evidence concerns the gene BCL2L15 and colorectal carcinoma.